Search Results - "Alone, Mitali"

Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial by Chopra, Supriya, Gupta, Sudeep, Kannan, Sadhana, Dora, Tapas, Engineer, Reena, Mangaj, Akshay, Maheshwari, Amita, Shylasree, T Surappa, Ghosh, Jaya, Paul, Siji N, Phurailatpam, Reena, Charnalia, Mayuri, Alone, Mitali, Swamidas, Jamema, Mahantshetty, Umesh, Deodhar, Kedar, Kerkar, Rajendra, Shrivastava, Shyam K

“…Postoperative Adjuvant Radiation in Cervical Cancer (PARCER), a phase III randomized trial, compared late toxicity after image-guided intensity-modulated…”
Get full text

Neoadjuvant chemotherapy in locally advanced (T3-T4) external auditory canal carcinoma: A retrospective observational study by Rai, Rahul, Patil, Vijay, Alone, Mitali, Saha, Saswata, Tudu, Rajanigandha, Noronha, Vanita, Parekh, Deevyashali, Menon, Nandini, Ghosh-Laskar, Sarbani, Pai, Prathamesh, Prabhash, Kumar

Get full text

A Survey of Satisfaction with Treatment among Brain Tumor Patients by Singh, Gunjesh Kumar, Alone, Mitali, Menon, Nandini, Dale, Ochin, Bhelekar, Arti, Patil, Vijay M.

Get full text

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study by Patil, Vijay Maruti, Noronha, Vanita, Menon, Nandini, Rai, Rahul, Bhattacharjee, Atanu, Singh, Ajay, Nawale, Kavita, Jogdhankar, Shweta, Tambe, Rupali, Dhumal, Sachin, Sawant, Riddhi, Alone, Mitali, Karla, Devanshi, Peelay, Zoya, Pathak, Shruti, Balaji, Arun, Kumar, Suman, Purandare, Nilendu, Agarwal, Archi, Puranik, Ameya, Mahajan, Abhishek, Janu, Amit, Kumar Singh, Gunjesh, Mittal, Neha, Yadav, Subhash, Banavali, Shripad, Prabhash, Kumar

“…The regimens approved for the treatment of advanced head and neck squamous cell carcinoma are accessible to only 1%-3% of patients in low- and middle-income…”
Get full text

Safety and efficacy of pembrolizumab with chemotherapy in locally advanced head and neck cancers by Patil, Vijay, Alone, Mitali, Rai, Rahul, Noronha, Vanita, Menon, Nandini, Prabhash, Kumar

Get full text

Salvage (Re)radiation in Oligometastatic and Oligorecurrent Cervical Cancer by Chopra, Supriya, Kalra, Babusha, Mulani, Jaahid, Jain, Jeevanshu, Gurram, Lavanya, Mittal, Prachi, Alone, Mitali, Ghosh, Jaya, Rath, Sushmita, Gulia, Seema, Gupta, Sudeep

“…In patients with recurrent or metastatic cervical cancer, the median survival time is 13 to 24 months based on the choice of palliative systemic chemotherapy…”
Get full text

Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation by Patil, Vijay Maruti, Noronha, Vanita, Menon, Nandini, Singh, Ajay, Ghosh-Laskar, Sarbani, Budrukkar, Ashwini, Bhattacharjee, Atanu, Swain, Monali, Mathrudev, Vijayalakshmi, Nawale, Kavita, Balaji, Arun, Peelay, Zoya, Alone, Mitali, Pathak, Shruti, Mahajan, Abhishek, Kumar, Suman, Purandare, Nilendu, Agarwal, Archi, Puranik, Ameya, Pendse, Shantanu, Reddy Yallala, Monica, Sahu, Harsh, Kapu, Venkatesh, Dey, Sayak, Choudhary, Jatin, Krishna, Madala Ravi, Shetty, Alok, Karuvandan, Naveen, Ravind, Rahul, Rai, Rahul, Jobanputra, Kunal, Chaturvedi, Pankaj, Pai, Prathamesh S, Chaukar, Devendra, Nair, Sudhir, Thiagarajan, Shivakumar, Prabhash, Kumar

“…There is a lack of published literature on systemic therapeutic options in cisplatin-ineligible patients with locally advanced head and neck squamous cell…”
Get full text

Real world evidence for use of NACT in locally advanced external auditory canal cancer by Rai, Rahul Kumar, Patil, Vijay Maruti, Noronha, Vanita, Menon, Nandini Sharrel, Saha, Saswata, Alone, Mitali, Pai, P. S., Laskar, Sarbani, Prabhash, Kumar

“…e18000 Background: The management of very locally advanced external auditory canal cancers (LAEACC) is complicated, has a dismal prognosis and there is limited…”
Get full text

Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer by Patil, Vijay, Kumar, Sravan, Noronha, Vanita, Menon, Nandini, Nawale, Kavita Prakash, Alone, Mitali, Waratkar, Gopichand, Dhumal, Sachin, Bhattacharjee, Atanu, Prabhash, Kumar

“…•Cabazitaxel had inferior PFS in comparison to docetaxel.•Cabazitaxel has inferior OS in comparison to docetaxel.•Age and site of disease influence OS…”
Get full text

Phase 3 randomised study evaluating the addition of low-dose nivolumab to palliative chemotherapy in head and neck cancer by Patil, Vijay Maruti, Noronha, Vanita, Menon, Nandini Sharrel, Bhattacharjee, Atanu, Kumar, Suman, Purandare, Nilendu, Agrawal, Archi, Puranik, Ameya, Nawale, Kavita Prakash, Jogdhankar, Shweta, Alone, Mitali, Tambe, Rupali, Sawant, Riddhi, Kalra, Devanshi, Dhumal, Sachin Babanrao, Banavali, Shripad Dinanath, Prabhash, Kumar

“…LBA6016 Background: The regimens approved for the treatment of advanced head and neck squamous cell carcinoma (HNSCC) are accessible to only 1-3% of patients…”
Get full text

Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer by Noronha, Vanita, Patil, Vijay, Chaturvedi, Pankaj, Mathrudev, Vijayalakshmi, Menon, Nandini, Bhattacharjee, Atanu, Singh, Ajay, Peelay, Zoya, Chakraborty, Shatabdi, Jadhav, Monica, Alone, Mitali, Bhagyavant, Priyanka, Kolkur, Manali, Srinivas, Sujay, Das, Sudeep, Roy, Somnath, Mandal, Tanmoy, Dsouza, Hollis, Saha, Saswata, Rai, Rahul, Srikanth, Anne, Shah, Darshit, Khan, Arif, Muthuluri, Hemanth, Kumar, Amit, Agarwal, Amit, Rajpurohit, Anu, Goli, Vasu Babu, Sekar, Anbarasan, Mantri, Anoop, Kanteti, Aditya Pavan Kumar, Majumdar, Swaratika, Khaddar, Satvik, Shenoy, Ramnath, Elamarthi, Prahlad, Rathnasamy, Narmadha, Kashyap, Lakhan, Abraham, George, Booma, Naveen, Simha, Vijay, Chaukar, Devendra, Pai, Prathamesh, Nair, Sudhir, Laskar, Sarbani, Nawale, Kavita, Naidu, Priyanka, Salian, Sushmita, Shelar, Priyanka, Raulo, Ravinarayan, Dhumal, Sachin Babanrao, Prabhash, Kumar

“…Neoadjuvant chemotherapy (NACT) with TPF (docetaxel, cisplatin, and 5FU) is one of the treatment options in very locally advanced oral cancer with a survival…”
Get full text